The Group's principal activities are to manufacture and develop chemicals used in biochemical, pharmaceutical and other life science research applications.
Diabetes
Siemens Healthcare Diagnostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis, monitoring and management of disease. Our products and services offer the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
Novartis Pharmaceuticals Corporation researches, develops manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, respiratory, dermatology and infectious disease areas.
NeuroMetrix is a science-based company advancing patient care through the development and marketing of innovative medical devices and products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and that provide regional anesthesia and pain control.
Echo Therapeutics is a transdermal medical device and specialty pharmaceuticals company.
Echo's Symphony™ tCGM System is a non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system focused on changing the paradigm of invasive, episodic glucose testing in diabetes home use and hospital critical care markets.
Alkermes focuses on therapies for widespread, chronic diseases, such as central nervous system disorders, addiction, diabetes and autoimmune disorders, where we feel we have the opportunity to make the greatest impact.
MicroCHIPS is pioneering intelligent implanted devices designed to improve the health of millions of people with chronic conditions that require careful monitoring and precise therapy.